Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What I don't understand is: Why aren't insiders buying??????
...
...
;D
Oh, the games that get played...!
A plan for achieving higher liquidity has already been communicated: i.e., up-listing.
Granted, the specifics of how to achieve said up-listing have not been communicated... But, FWIW, my strictly personal opinion is that one has to read between the lines there. (I.e., there are only so many ways this can be pulled-off.)
Meanwhile, the "Powered by Lexaria" logo on Cannadips packaging should help furnish more interest as well. ("Organically" if you will - for lack of a better word.)
Yes - this.
This mistake's been made on this board before. "Shareholder of Record" means whomever is (basically) holding the shares "on behalf of" the actual/real shareholder.
"AgentSmith" is not a shareholder of record, for instance; but "E*TRADE", "AmeriTrade", etc. are.
Methinks an "Altria" announcement would put much of this into swift motion.
The company can only do so much to try and communicate some things...
Strictly my $0.02.
FWIW - I agree with everything you've said.
"Painful" - if you're staring at a bunch of red, no doubt...
But also "glorious" - if you're able to take advantage...
So goes Mr. Market.
You know... IR might be able to enlighten you as to why they aren't electing to do this - it is a fair question. But I suspect for everyone here it's just tea leaves.
Unless you're frustrated and ranting/venting, or (gasp) trying to sow doubt - both of which are entirely your prerogative - I, for one, humbly offer that this horse has long been dead, pretty much flattened-out, and beginning to go rancid.
Insiders aren't buying.
Maybe it's because they know it's all going to hell in a hand-basket.
Maybe it's because they're all poor now because the value of their existing positions has been decimated, and their kids need braces.
Maybe it's because there's a deal around the corner and they'd all be going to jail if they did.
Maybe it's because there's a deal in place that restricts/prevents them from buying.
We don't know why - we're not insiders. (I'm figuring/assuming.)
But they aren't doing it.
We get it.
With all the mistakes I've made investigating thus far ... I'm so, so glad I somehow had the wherewithal to stay away from Rivers.
Right - "Bypassing your liver from my kitchen boooiii!!"
Classic.
I'm going to go ahead and put this out there - complete speculation, of course.
It stands to reason that Lexaria and Canopy have dealt with one another before...
And I strongly believe Chris and team were brushed aside by Bruce Linton at that time. I even suspect that it was something akin to: "We'll figure it out without needing your fancy-shmancy tech ah-thank-you-very-much. We're going to be huge, and you're just going to disappear into the oblivion. *door-slam*"
(Or, possibly, Linton wanted the whole enchilada for peanuts - claiming it was "just some unproven devil-magic" - and Chris was like: "Hard. Pass.")
I say this because there was a time when Chris could be seen on video, at events, referring to Canopy with resentment if not downright contempt in his voice - he seemed very emotional about Canopy.
All's to say, I think they've dealt with one another, and Lexaria walked-away feeling dismissed. And, well... Perhaps this is "the chickens have come home to roost."
Like I said - complete speculation; but just my $0.02, as usual.
FWIW, I think it's quite the opposite - i.e., it means they can't afford to "get it wrong" again.
Meaning, I think they're going to want/expect DehydraTECH to be absolutely-positively-100%-beyond-any-measure-of-a-doubt ironed-out before they move on it with conviction. I think this is why we're all sitting here, twiddling our thumbs, while the seemingly endless R&D continues.
There is no way the top brass at Altria are pitching something like "revolutionary absorption technology from a little bioscience company in Kelowna" to their Board and shareholders until they're confident it's an absolute slam-dunk; not after JUUL was so publicly not one.
It's either (a) a US-only exclusive license, or (b) a buyout of Lexaria Nicotine.
I.e., either (a) Lexaria gets a royalty off of every product Altria sells (that leverages Lexaria tech) and Altria gets the exclusive competitive advantage in the US market, or (b) Lexaria gets a massive cash infusion in exchange for divesting itself of the nicotine business entirely (and probably puts that money into - yes, some executive compensation, but also - building-out Pharma, Cannabis, and/or Hemp.)
Personally, I think the pharma implications of Lexaria tech will ultimately drawf any of the others - including nicotine - and so wouldn't mind it at all if the company decided to trade the R&D/IP rights there for a lump sum to invest into Lexaria Pharma.
My $0.02, as usual.
Dude - we're gonna get soooooo much tail...!!
What a great time to be alive! (All things considered...)
I genuinely believe this will prove to be the deal that's going to light the fuse on the Lexaria powder-keg.
Altria (i.e., an impressive partnership, still in research phase), Hill Street (i.e., a niche brand, with a niche product, still tackling production woes), ChrgD+ (i.e., your own "showcase" product, still working on gaining distribution traction), etc. - these are all great irons in the fire.
But... When you get a company with (1) a recognizable brand, (2) a market-leading product, and (3) established distribution channels - and expansion and more SKU plans in the works, to boot - going out there and saying: "We're already the best at what we do; and we're staking all that on Lexaria keeping us there for the foreseeable future."
... that is a whole other ball o' wax.
People will notice; especially people that are no doubt growing more and more worried with each passing day - and each deal (like this one) that gets done - about "missing the boat" on some key piece of patent-protected (!!) tech/IP that's ultimately going to prove to have cinched the market for a competitor.
(A note about patents: Keep in mind - with each deal that gets done, now it's not just "a little Kelowna company" that's coming after you if you steal/duplicate their tech: it's everyone they deal with that's now coming after you for loses.)
IMHO this is a "game changer" deal - this is an established brand and product, with market leadership at stake, going all-in on Lexy tech.
No research partner wishy-washiness, no "it'll be great when we can get a product into the market" wait-and-see; this deal establishes Lexaria; and other companies will find themselves forced to give it (even) more serious consideration now.
https://www.proactiveinvestors.com/companies/news/910938/lexaria-bioscience-and-cannadips-ceos-discuss-key-point-of-massive-deal-together-910938.html
I honestly couldn't be more excited to see what becomes of Lexaria in 2020.
From slow-bleeding down every day to inching up every day! Woot woot!!
Knew I shoulda put that order in at $0.32...! The "black swan" perils of trying to time things in the market... XD
Pffsssshhh - LXRP eats news for breakfast.
Up nearly 30% because CEO said "all's well." XD
Agreed on all points.
PR like this is a mixed blessing... On the one hand, it's nice - and was arguably necessary at this point - but on the other, it begs the question of whether or not this is what we got because this is all the company has to give us (anytime soon). Who knows.
All that said, "I'll take it." XD
This pop - whether short-lived or not - will hopefully communicate to Bunka that we believe in Lexaria, but communication matters.
Okay good - I wouldn't be a fan of this myself.
Thanks for sharing.
Unless you're just "done" with it - I'd suppose - you don't sell a company based on what the market claims it's "worth today" - you sell it based on its future revenue potential (i.e., the money it'll be bringing-in year after year after year).
(If someone hits you with their car, and you incur an injury that makes it impossible for you to work, would you sue them for your "annual salary at the time of the accident", or "all lost income - today and future"?)
$24M would be a laughable joke for technology that could potentially prove paradigm-shifting in drug delivery.
If Bunka sold for a figure like this, I'd have to reason that either (a) he/something is quite unwell, or (b) the tech is actually garbage, and he knows it is.
EDIT: Also, yes - what PotsAndPans said.
The 10-Q... "leaves much to be desired."
Not surprised we can expect a "Letter from the CEO" - some serious damage control is needed, methinks. (For the short term.)
Strictly my $0.02, as usual.
Noice.
Frankly, I'd expect this to be the usual end-o'-the-year, "recap of 2019 & here's looking at you, 2020" deal. (Probably with some remarks about the share price action.)
I'd be quite surprised if he reveals anything a company would otherwise be expected to announce via PR.
(Meanwhile, waiting on the sidelines with bated breath - trying to time a falling knife...)
eyeroll
Does anyone have a photo of the building for "Plan B Contractors, Inc." - I wanna be sure they're not just some scam company set-up by "Lexaria Bioscience" to put fake company photos on the internet; you know - before I go all in on Lexaria.
(Also, if you could post a selfie too while you're at it - so I know you're a real person, and not some bot put together by either of the potentially scam companies "Lexaria Bioscience" and/or "Plan B Contractors, Inc." - that'd be swell too.)
Like I said: Just trying to do my DD before going all in on an OTC penny stock.
Maybe; maybe not.
I don't get to - or want to, to be honest - watch it all that closely.
Seemed "plenty cheap" to me; so I pulled the trigger. (Heck - I never thought we'd see $0.50 again back in the day.)
Nibbled here. shrug